A Randomized, Double-Blind, Placebo-Controlled Trial Using Cannabidiol and Palmitoylethanolamide for the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet
Latest Information Update: 08 May 2024
At a glance
- Drugs Cannabidiol/palmitoylethanolamide (Primary)
- Indications Diabetic neuropathies; Neuropathic pain; Peripheral neuropathies
- Focus Therapeutic Use
Most Recent Events
- 20 Mar 2023 New trial record